Attention: This platform is in beta mode. Expect some changes and adjustments.

AI Market Mood: Stock Dashboard

ADCT


Fundamental

Company: Adc Therapeutics SA
Sector: Healthcare
Industry: Biotechnology
Country: Switzerland
Exchange: NYSE
Index: RUT
P/E: -
EPS (ttm): -1.45
Insider Own: 21.71%
Shs Outstand: 99.18M
Perf Week: -6.15%
Market Cap: 302.49M
Forward P/E: -
EPS next Y: -1.31
Insider Trans: 0.00%
Shs Float: 77.65M
Perf Month: 10.11%
Enterprise Value: 564.60M
PEG: -
EPS next Q: -0.39
Inst Own: 74.10%
Short Float: 6.32%
Perf Quarter: 147.97%
Income: -149.84M
P/S: 3.99
EPS this Y: 8.89%
Inst Trans: 33.53%
Short Ratio: 6.61
Perf Half Y: 66.67%
Sales: 75.82M
P/B: -
EPS next Y Percentage: 11.38%
ROA: -51.62%
Short Interest: 4.91M
Perf YTD: 53.27%
Book/sh: -2.40
P/C: 1.55
EPS next 5Y: 16.36%
ROE: -
52W High: 3.98 -23.41%
Perf Year: -16.89%
Cash/sh: 1.96
P/FCF: -
EPS past 3/5Y: 18.47% 1.38%
ROIC: -71.25%
52W Low: 1.05 190.48%
Perf 3Y: -62.35%
Dividend Est.: -
EV/EBITDA: -
Sales past 3/5Y: 27.82% 97.79%
Gross Margin: 88.48%
Volatility W: 5.92%
Volatility M: 7.43%
Perf 5Y: -93.24%
Dividend TTM: -
EV/Sales: 7.45
EPS Y/Y TTM: 47.31%
Oper. Margin: -165.54%
ATR (14): 0.24
Perf 10Y: -
Dividend Ex-Date: -
Quick Ratio: 4.16
Sales Y/Y TTM: 10.49%
Profit Margin: -197.64%
RSI (14): 51.94
Recom: 1.00
Dividend Gr. 3/5Y: - -
Current Ratio: 4.46
EPS Q/Q: 36.22%
SMA20: 3.11%
Beta: 1.93
Target Price: 8.25
Payout: -
Debt/Eq: -
Sales Q/Q: 27.59%
SMA50: 7.93%
Rel Volume: 0.79
Prev Close: 3.14
Employees: 265
LT Debt/Eq: -
Earnings: May 14 BMO
SMA200: 37.95%
Avg Volume: 741.85K
Price: 3.05
IPO: May 15, 2020
Option/Short: Yes / Yes
EPS/Sales Surpr.: 10.74% 30.06%
Trades:
Volume: 583,016
Change: -2.87%

Technical:


Latest News:

Cullinan stock rises on Amgen's Blincyto data (NASDAQ:CGEM) | Seeking Alpha very bullish
CGEM AMGN ADCT ALLO AZN AUTL BMY IPSC GILD MOR NKTX NVS

Summary: Cullinan Therapeutics (CGEM) stock surged ~58% last week after positive data for CD19-targeting therapy similar to competitor Amgen's Blincyto, showing efficacy against autoimmune diseases like rheumatoid arthritis and systemic sclerosis.

Full article
2024-04-27T19:44:12Z